Global chemical company Evonik has announced that VECOLLAN®, its recombinant, non-animal-derived collagen-like protein ...

Kraig Biocraft Laboratories, Inc. (OTCQB: KBLB) ("Company" or "Kraig Labs"), a world leader in spider silk technology*, today announced that it is actively pursuing the acquisition of an additional ...

Vaxart, Inc. (OTCQX: VXRT) (“Vaxart” or the “Company”), a clinical-stage biotechnology company developing a range of oral recombinant pill vaccines based on its proprietary delivery platform, ...

Amphastar Pharmaceuticals ( ($AMPH) ) just unveiled an update. On September 15, 2025, Amphastar Pharmaceuticals entered into a contract research ...

Novavax, Inc.’s outlook improves with a Sanofi partnership and upgraded 2025 revenue guidance. Click here to find out why ...

The global research antibodies and reagents market is projected to grow at a CAGR of 7% from 2025 to 2030, driven by ...

Vaxart, Inc. (OTCQX: VXRT) ("Vaxart" or the "Company"), a clinical-stage biotechnology company developing a range of oral recombinant pill ...

What if you'd invested in Halozyme Therapeutics (HALO) ten years ago? It may not have been easy to hold on to HALO for all that time, but if you did, how much would your investment be worth today?

Russian pharmaceutical company Medsintez and VNVC Vaccine and Biopharmaceutical Manufacturing Plant have signed a ...

On 03 September 2025, Hoffmann-La Roche conducted a study is to assess the long-term safety and to explore the efficacy of ...

FUJIFILM Biosciences launches BalanCD HEK293 Perfusion A to boost scalable viral vector production for gene therapy.